N-/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbits

Glycobiology

Volumn 23, Issue 12, 2013, Pages 1531-1546

  Chevreux, Guillaume ^a   Faid, Valegh ^a   Scohyers, Jean Marc ^a   Bihoreau, Nicolas ^a  

^a LFB Biotechnologies   (France)

Author keywords

Coagulation factor VII; Glycosylation; Mass spectrometry; Transgenic

Indexed keywords

2 AMINOBENZAMIDE; BETA CASEIN; BLOOD CLOTTING FACTOR 7A; DODECYL SULFATE SODIUM; FUCOSE; GLYCAN; MONOSACCHARIDE; N ACETYL BETA GLUCOSAMINIDASE; N GLYCOLOYLNEURAMINIC ACID; OLIGOSACCHARIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SIALIC ACID; XYLOSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DEGLYCOSYLATION; EXPERIMENTAL RABBIT; FEMALE; GLYCOSYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST CELL; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LACTATION; MAMMARY GLAND; MASS SPECTROMETRY; METHYLATION; MILK; MILK PRODUCTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIALYLATION; TANDEM MASS SPECTROMETRY; TRANSGENIC ANIMAL; TRANSGENICS; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; RABBIT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; FACTOR VIIA; GLYCOSYLATION; HUMANS; MAMMARY GLANDS, HUMAN; MILK; RABBITS;

EID: 84887961211     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwt085     Document Type: Article

References (40)

1. Aoki N, Ujita M, Kuroda H., Urabe M, Noda A, Adachil T., Nakamura R, Matsuda T. 1994. Immunologically cross-reactive 57 kDa and 53 kDa glyco-protein antigens of bovine milk fat globule membrane: Isoforms with different N-linked sugar chains and differential glycosylation at early stages of lactation. Biochim Biophys Acta. 1200:227-234.
2. Bolt G, Kristensen C, Steenstrup TD 2005. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII. Glycobiology. 15:541-547.
3. Brinkhous KM, Hedner U, Garris J.B., Diness V., Read MS 1989. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease. Proc Natl Acad Sci USA. 86:1382-1386.
4. Britten CJ, van den Eijnden DH, McDowell W, Kelly VA, Witham SJ, Edbrooke MR, Bird MI, de Vries T, Smithers N. 1998. Acceptor specificity of the human leukocyte alpha3 fucosyltransferase: Role of FucT-VII in the generation of selectin ligands. Glycobiology. 8:321-327.
5. Carugati A, Pappalardo E, Zingale L.C., Cicardi M. 2001. C1-inhibitor deficiency and angioedema. Mol Immunol. 38:161-173.
6. Chiu MH, Tamura T, Wadhwa M.S., Rice KG 1994. In vivo targeting function of N-linked oligosaccharides with terminating galactose and N- acetylgalactosamine residues. J Biol Chem. 269:16195-16202.
7. Ciucanu I, Kerek F. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res. 131:209-217.
8. Domon B, Costello CE 1988. Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry. 27:1534-1543.
9. Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R., Higgins E, Manavalan P, Ziomek C., Meade H, McPherson JM, et al 1998. Transgenically produced human antithrombin: Structural and functional comparison to human plasma-derived antithrombin. Blood. 91:4561-4571.
10. Fenaille F, Groseil C, Ramon C., Riande S, Siret L, Chtourou S., Bihoreau N. 2008. Mass spectrometric characterization of N- and O-glycans of plasma-derived coagulation factor VII. Glycoconj J. 25:827-842.
11. Gil GC, Velander WH, Van Cott KE. 2008. Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk. Glycobiology. 18:526-539.
12. Hansson K, Stenflo J. 2005. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost. 3:2633-2648.
13. Hedner U, Lee CA 2011. First 20 years with recombinant FVIIa (NovoSeven). Haemophilia. 17:e172-e182.
14. Jongen SP, Gerwig GJ, Leeflang B.R., Koles K., Mannesse ML, van Berkel PH, Pieper FR, Kroos MA, Reuser AJ, Zhou Q, et al 2007. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits. Glycobiology. 17:600-619.
15. Joziasse DH, Schiphorst WE, van den Eijnden DH, van Kuik JA, van Halbeek H, Vliegenthart JF. 1985. Branch specificity of bovine colostrum CMP-sialic acid: N-acetyllactosaminide alpha 2-6-sialyltransferase. Interaction with biantennary oligosaccharides and glycopeptides of N-glycosylproteins. J Biol Chem. 260:714-719.
16. Kamerling JP, Boons G-J. 2007. Comprehensive Glycoscience: From Chemistry to Systems Biology. 1st ed. Amsterdam; Boston: Elsevier.
17. Klausen NK, Bayne S, Palm L. 1998. Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VIIa by gly-cosidase digestions, liquid chromatography, and mass spectrometry. Mol Biotechnol. 9:195-204.
18. Koles K, van Berkel PH, Pieper FR, Nuijens JH, Mannesse ML, Vliegenthart J.F., Kamerling JP 2004a. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Glycobiology. 14:51-64.
19. Koles K, van Berkel PH, Mannesse ML, Zoetemelk R, Vliegenthart JF, Kamerling JP 2004b. Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits. Glycobiology. 14:979-986.
20. Landberg E, Huang Y, Stromqvist M., Mechref Y, Hansson L, Lundblad A., Novotny MV, Pahlsson P. 2000. Changes in glycosylation of human bile-salt-stimulated lipase during lactation. Arch Biochem Biophys. 377:246-254.
21. Lusher J, Ingerslev J, Roberts H., Hedner U. 1998. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis. 9:119-128.
22. Maertens L, Lebas F, Szendrö Z. 2006. Rabbit milk: A review of quantity, quality and non-dietary affecting factors. World Rabbit Sci. 14:205-230.
23. Menache D, Grossman BJ, Jackson CM 1992. Antithrombin III: Physiology, deficiency, and replacement therapy. Transfusion. 32:580-588.
24. Montesino R, Toledo JR, Sanchez O, Sanchez A., Harvey DJ, Royle L, Dwek RA, Rudd P.M., Gerwig GJ, Kamerling JP, et al 2008. Monosialylated bian-tennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk. Arch Biochem Biophys. 470:163-175. Epub 2007 Dec 2005.
25. Morelle W, Faid V, Michalski JC 2004. Structural analysis of permethylated oligosaccharides using electrospray ionization quadrupole time-of-flight tandem mass spectrometry and deutero-reduction. Rapid Commun Mass Spectrom. 18:2451-2464.
26. Nimtz M, Wray V, Rudiger A., Conradt HS 1995. Identification and structural characterization of a mannose-6-phosphate containing oligomannosidic N-glycan from human erythropoietin secreted by recombinant BHK-21 cells. FEBS Lett. 365:203-208.
27. Packer NH, Lawson MA, Jardine D.R., Redmond JW 1998. A general approach to desalting oligosaccharides released from glycoproteins. Glycoconj J. 15:737-747.
28. Park EI, Manzella SM, Baenziger JU 2003. Rapid clearance of sialylated gly-coproteins by the asialoglycoprotein receptor. J Biol Chem. 278:4597-4602.
29. Reitman ML, Kornfeld S. 1981a. Lysosomal enzyme targeting. N-Acetylglucosaminylphosphotransferase selectively phosphorylates native lysosomal enzymes. J Biol Chem. 256:11977-11980.
30. Reitman ML, Kornfeld S. 1981b. UDP-N-acetylglucosamine: glycoprotein N-acetylglucosamine-1-phosphotransferase. Proposed enzyme for the phos-phorylation of the high mannose oligosaccharide units of lysosomal enzymes. J Biol Chem. 256:4275-4281.
31. Rice KG, Chiu MH, Wadhwa M.S., Thomas VH, Stubbs HJ 1995. In vivo targeting function of N-linked oligosaccharides. Pharmacokinetic and biodistribution of N-linked oligosaccharides. Adv Exp Med Biol. 376:271-282.
32. Sorensen AL, Clausen H, Wandall HH 2012. Carbohydrate clearance receptors in transfusion medicine. Biochim Biophys Acta. 1820:1797-1808.
33. Tomokiyo K, Yano H, Imamura M., Nakano Y, Nakagaki T, Ogata Y., Terano T, Miyamoto S, Funatsu A. 2003. Large-scale production and properties of human plasma-derived activated Factor VII concentrate. Vox Sang. 84:54-64.
34. van Berkel P.H., Welling MM, Geerts M, van Veen HA, Ravensbergen B, Salaheddine M, Pauwels E.K., Pieper F., Nuijens JH, Nibbering PH 2002. Large scale production of recombinant human lactoferrin in the milk of trans-genic cows. Nat Biotechnol. 20:484-487.
35. Van Cott K.E., Velander WH 1998. Transgenic animals as drug factories: A new source of recombinant protein therapeutics. Expert Opin Investig Drugs. 7:1683-1690.
36. Varki A. 1993. Biological roles of oligosaccharides: All of the theories are correct. Glycobiology. 3:97-130.
37. Vella GJ, Paulsen H, Schachter H. 1984. Control of glycoprotein synthesis. IX. A terminal Man alpha l-3Man beta 1-sequence in the substrate is the minimum requirement for UDP-N-acetyl-D-glucosamine: Alpha-D-mannoside (GlcNAc to Man alpha 1-3) beta 2-N-acetylglucosaminyltransferase I. Can J Biochem Cell Biol. 62:409-417.
38. Viseux N, de Hoffmann E, Domon B. 1997. Structural analysis of permethy-lated oligosaccharides by electrospray tandem mass spectrometry. Anal Chem. 69:3193-3198.
39. Waheed A, Hasilik A, von Figura K. 1982. UDP-N-acetylglucosamine: lyso-somal enzyme precursor N-acetylglucosamine-1-phosphotransferase. Partial purification and characterization of the rat liver Golgi enzyme. J Biol Chem. 257:12322-12331.
40. Yu T, Guo C, Wang J., Hao P, Sui S, Chen X., Zhang R, Wang P, Yu G., Zhang L, et al 2010. Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle. Glycobiology. 21:206-224.